Sakai-Bizmark, Rie http://orcid.org/0000-0003-2452-5832
Kumamaru, Hiraku
Marr, Emily H.
Bedel, Lauren E. M.
Mena, Laurie A.
Baghaee, Anita
Nguyen, Michael
Estevez, Dennys
Wu, Frank
Chang, Ruey-Kang R.
Funding for this research was provided by:
National Institutes of Health (NHLBI K01141697)
Article History
Received: 10 January 2022
Accepted: 6 October 2022
First Online: 23 October 2022
Declarations
:
: Dr. Chang is the founder, CEO, and majority shareholder of QT Medical. QT Medical manufactures ECG devices. Dr. Chang is also the founder and CEO of NeoVative, a Research & Development company for wearable medical devices. The authors declare that there is no conflict of interest regarding the study.
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the 1964 Declaration of Helsinki and its later amendment. The study was approved by Lundquist Institute for Biomedical Innovation IRB (18CR-32121-01).